Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jana HofRenate Kirschner-Schwabe


In the clinical management of children with relapsed acute lymphoblastic leukemia (ALL), treatment resistance remains a major challenge. Alterations of the TP53 gene are frequently associated with resistance to chemotherapy, but their significance in relapsed childhood ALL has remained controversial because of small studies. Therefore, we systematically studied 265 first-relapse patients enrolled in the German Acute Lymphoblastic Leukemia Relapse Berlin-Frankfurt-Mü nster 2002 (ALL-REZ BFM 2002) trial for sequence and copy number alterations of the TP53 gene by using direct sequencing and multiplex ligation-dependent probe amplification. We observed copy number and sequence alterations of TP53 in 12.4% (27 of 218) of patients with B-cell precursor ALL and 6.4% (three of 47) of patients with T-cell ALL relapse. Backtracking to initial ALL in 23 matched samples revealed that 54% of all TP53 alterations were gained at relapse. Within B-cell precursor ALL, TP53 alterations were consistently associated with nonresponse to chemotherapy (P < .001) and poor event-free survival (P < .001) and overall survival rates (P = .002). TP53 alterations also had a significant impact on survival within intermediate-risk (S2) and high-risk (S3/S4) ...Continue Reading


Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S J KuerbitzM B Kastan
Feb 25, 1992·Nucleic Acids Research·A SerraG Saglio
Feb 1, 1992·The Journal of Clinical Investigation·C A FelixJ Whang-Peng
May 19, 2001·Journal of Medical Genetics·A ChompretC Bonaïti-Pellié
Mar 7, 2002·Journal of Pediatric Hematology/oncology·J GumpS P Hunger
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hagen Graf EinsiedelGünter Henze
Aug 11, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Renate Kirschner-SchwabeKarl Seeger
Jun 15, 2007·Bone Marrow Transplantation·L ScruccaF Aversa
Dec 21, 2007·The New England Journal of Medicine·M Luana PoetaWayne M Koch
Nov 29, 2008·Science·Charles G MullighanJames R Downing
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gesche TallenArend von Stackelberg
Aug 11, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thorsten ZenzStephan Stilgenbauer
Aug 13, 2010·British Journal of Haematology·Christine J HarrisonUNKNOWN Biology and Diagnosis Committee of International Berlin-Frankfürt-Münster study group

❮ Previous
Next ❯


Apr 25, 2012·Current Hematologic Malignancy Reports·Ilaria IacobucciGiovanni Martinelli
Mar 26, 2013·Lancet·Hiroto InabaCharles G Mullighan
May 4, 2013·The Lancet Oncology·Deepa Bhojwani, Ching-Hon Pui
Jan 22, 2013·Nature Genetics·Linda HolmfeldtCharles G Mullighan
Oct 2, 2012·The Journal of Clinical Investigation·Charles G Mullighan
Dec 10, 2013·Hematology·Andrea Biondi, Giovanni Cazzaniga
Jun 19, 2013·Journal of Hematology & Oncology·Yanmin ZhaoGuoqing Wei
Nov 23, 2013·Cancer Letters·Tom Van MaerkenJo Vandesompele
Dec 2, 2014·Pediatric Clinics of North America·Stacy L Cooper, Patrick A Brown
Oct 13, 2015·Pediatrics International : Official Journal of the Japan Pediatric Society·Hiroaki Goto
Dec 25, 2015·European Journal of Medical Genetics·Christian Peter KratzHélène Cavé
Mar 15, 2016·The Journal of Clinical Investigation·Ying ChengWei Tong
Jul 4, 2012·Pediatric Blood & Cancer·Hernan CarolRichard B Lock
Jan 15, 2014·Human Mutation·Jitka MalcikovaSarka Pospisilova
May 1, 2016·Annals of Diagnostic Pathology·Yi ZhouCarlos E Bueso-Ramos
Aug 25, 2015·The Journal of Clinical Investigation·Jesús Duque-AfonsoMichael L Cleary
Aug 14, 2015·BMC Cancer·Louise van der WeydenDavid J Adams
Apr 26, 2014·Pediatric Hematology and Oncology·Emma HonkaniemiBritt Gustafsson
Jul 12, 2014·Blood·Anthony V Moorman
Mar 18, 2015·Nature Reviews. Clinical Oncology·Kathryn G Roberts, Charles G Mullighan
Apr 12, 2014·Frontiers in Oncology·Kathrin M Bernt, Stephen P Hunger
May 20, 2016·Cancer Chemotherapy and Pharmacology·Raushan T Kurmasheva, Peter J Houghton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.